These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 2206032

  • 21. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S, Bentivoglio M, Conti R, Osanna RA, Savino K, Zollino L, Corea L.
    Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
    [Abstract] [Full Text] [Related]

  • 22. Treatment of combined hyperlipidemia with lovastatin versus gemfibrozil: a comparison study.
    Ojala JP, Helve E, Tikkanen MJ.
    Cardiology; 1990 Apr; 77 Suppl 4():39-49. PubMed ID: 2073671
    [Abstract] [Full Text] [Related]

  • 23. Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study.
    Tikkanen MJ, Laakso M, Ilmonen M, Helve E, Kaarsalo E, Kilkki E, Saltevo J.
    Diabetes Care; 1998 Apr; 21(4):477-81. PubMed ID: 9571327
    [Abstract] [Full Text] [Related]

  • 24. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
    Lane DM, Alaupovic P, Knight-Gibson C, Dudley VS, Laughlin LO.
    Am J Cardiol; 1995 Jun 01; 75(16):1124-9. PubMed ID: 7762498
    [Abstract] [Full Text] [Related]

  • 25. [Gemfibrozil reduces elevated lipoprotein (a) levels in hypercholesterolemic patients].
    Ramires JA, Spósito AC, Mansur AP, Solimene MC, Chamone D, da Luz PL, Pileggi F.
    Arq Bras Cardiol; 1997 Apr 01; 68(4):257-60. PubMed ID: 9497506
    [Abstract] [Full Text] [Related]

  • 26. Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia.
    Bradford RH, Shear CL, Chremos AN, Dujovne C, Franklin FA, Hesney M, Higgins J, Langendörfer A, Pool JL, Schnaper H.
    Am J Cardiol; 1990 Sep 18; 66(8):44B-55B. PubMed ID: 2206036
    [Abstract] [Full Text] [Related]

  • 27. Combination drug therapy for familial combined hyperlipidemia.
    East C, Bilheimer DW, Grundy SM.
    Ann Intern Med; 1988 Jul 01; 109(1):25-32. PubMed ID: 3288029
    [Abstract] [Full Text] [Related]

  • 28. The effect of gemfibrozil on lipid profile and glucose metabolism in hypertriglyceridaemic well-controlled non-insulin-dependent diabetic patients. For the Gemfibrozil Study Group.
    Avogaro A, Piliego T, Catapano A, Miola M, Tiengo A.
    Acta Diabetol; 1999 Jun 01; 36(1-2):27-33. PubMed ID: 10436249
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW, Huff M, Oskalns R, Rudas L, Kostuk WJ.
    J Heart Lung Transplant; 1995 Jun 01; 14(4):613-22. PubMed ID: 7578166
    [Abstract] [Full Text] [Related]

  • 31. Treatment of dyslipidemia in non-insulin-dependent diabetes mellitus with lovastatin.
    Garg A, Grundy SM.
    Am J Cardiol; 1988 Nov 11; 62(15):44J-49J. PubMed ID: 3055923
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
    Gutierrez MJ, Rosenberg NL, Macdougall DE, Hanselman JC, Margulies JR, Strange P, Milad MA, McBride SJ, Newton RS.
    Arterioscler Thromb Vasc Biol; 2014 Mar 11; 34(3):676-83. PubMed ID: 24385236
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
    Crespo N, Illnait J, Más R, Fernández L, Fernández J, Castaño G.
    Int J Clin Pharmacol Res; 1999 Mar 11; 19(4):117-27. PubMed ID: 10939029
    [Abstract] [Full Text] [Related]

  • 37. A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin.
    Nestel P, Simons L, Barter P, Clifton P, Colquhoun D, Hamilton-Craig I, Sikaris K, Sullivan D.
    Atherosclerosis; 1997 Mar 21; 129(2):231-9. PubMed ID: 9105566
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.
    Int J Clin Pharmacol Res; 2002 Mar 21; 22(3-4):89-99. PubMed ID: 12837046
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.